Evanson Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,827
| Closed | -$576K | – | 280 |
|
|
2021
Q1 | $576K | Sell |
3,827
-105
| -3% | -$15.8K | 0.09% | 146 |
|
|
2020
Q4 | $596K | Buy |
3,932
+170
| +5% | +$25.8K | 0.09% | 134 |
|
|
2020
Q3 | $509K | Buy |
3,762
+35
| +0.9% | +$4.74K | 0.09% | 126 |
|
|
2020
Q2 | $509K | Hold |
3,727
| – | – | 0.1% | 117 |
|
|
2020
Q1 | $402K | Buy |
3,727
+100
| +3% | +$10.8K | 0.1% | 129 |
|
|
2019
Q4 | $437K | Hold |
3,627
| – | – | 0.09% | 140 |
|
|
2019
Q3 | $361K | Hold |
3,627
| – | – | 0.07% | 154 |
|
|
2019
Q2 | $396K | Hold |
3,627
| – | – | 0.08% | 148 |
|
|
2019
Q1 | $405K | Hold |
3,627
| – | – | 0.08% | 142 |
|
|
2018
Q4 | $350K | Hold |
3,627
| – | – | 0.08% | 149 |
|
|
2018
Q3 | $442K | Sell |
3,627
-12
| -0.3% | -$1.46K | 0.09% | 138 |
|
|
2018
Q2 | $400K | Buy |
3,639
+12
| +0.3% | +$1.32K | 0.08% | 153 |
|
|
2018
Q1 | $387K | Sell |
3,627
-75
| -2% | -$8K | 0.08% | 159 |
|
|
2017
Q4 | $395K | Sell |
3,702
-27
| -0.7% | -$2.88K | 0.08% | 158 |
|
|
2017
Q3 | $415K | Buy |
3,729
+327
| +10% | +$36.4K | 0.09% | 138 |
|
|
2017
Q2 | $352K | Hold |
3,402
| – | – | 0.08% | 148 |
|
|
2017
Q1 | $333K | Sell |
3,402
-1,125
| -25% | -$110K | 0.08% | 149 |
|
|
2016
Q4 | $400K | Hold |
4,527
| – | – | 0.11% | 133 |
|
|
2016
Q3 | $437K | Hold |
4,527
| – | – | 0.12% | 113 |
|
|
2016
Q2 | $388K | Hold |
4,527
| – | – | 0.12% | 129 |
|
|
2016
Q1 | $394K | Hold |
4,527
| – | – | 0.13% | 118 |
|
|
2015
Q4 | $511K | Hold |
4,527
| – | – | 0.19% | 95 |
|
|
2015
Q3 | $458K | Hold |
4,527
| – | – | 0.17% | 106 |
|
|
2015
Q2 | $557K | Hold |
4,527
| – | – | 0.19% | 98 |
|
|
2015
Q1 | $518K | Sell |
4,527
-60
| -1% | -$6.87K | 0.19% | 102 |
|
|
2014
Q4 | $464K | Buy |
4,587
+60
| +1% | +$6.07K | 0.17% | 106 |
|
|
2014
Q3 | $413K | Sell |
4,527
-750
| -14% | -$68.4K | 0.17% | 112 |
|
|
2014
Q2 | $452K | Buy |
+5,277
| New | +$452K | 0.17% | 113 |
|